Anavex Life Sciences
AVXL
#7451
Rank
โ‚น36.70 B
Marketcap
โ‚น396.09
Share price
-6.37%
Change (1 day)
-50.47%
Change (1 year)

Market capitalization of Anavex Life Sciences (AVXL)

Market cap: โ‚น36.70 Billion

As of March 2026 Anavex Life Sciences has a market cap of โ‚น36.70 Billion. This makes Anavex Life Sciences the world's 7451th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Anavex Life Sciences from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น36.70 B25.73%
2025โ‚น29.19 B-66.87%
2024โ‚น88.11 B38.5%
2023โ‚น63.62 B6.5%
2022โ‚น59.73 B-39.11%
2021โ‚น98.11 B271%
2020โ‚น26.44 B150.84%
2019โ‚น10.54 B106.13%
2018โ‚น5.11 B-43.75%
2017โ‚น9.09 B-14.71%
2016โ‚น10.65 B-16.9%
2015โ‚น12.82 B1896.21%
2014โ‚น0.64 B10.53%
2013โ‚น0.58 B-55.56%
2012โ‚น1.30 B-25.45%
2011โ‚น1.75 B-57.31%
2010โ‚น4.10 B96.05%
2009โ‚น2.09 B-15.24%
2008โ‚น2.47 B-39.15%
2007โ‚น4.06 B77%
2006โ‚น2.29 B

End of Day market cap according to different sources

On Mar 17th, 2026 the market cap of Anavex Life Sciences was reported to be:

โ‚น39.20 Billion
by Nasdaq info icon info icon
โ‚น39.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น388.47 B 958.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น329.35 B 797.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น3.53 B-90.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น213.60 B 481.93%๐Ÿ‡บ๐Ÿ‡ธ USA